These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35130382)

  • 1. Determinants of patient and physician treatment satisfaction in moderate-to-severe psoriasis: a multinational survey of psoriasis patients.
    Teeple A; Villacorta R; PharmD SL; Fakharzadeh S; Lucas J; PhD NL
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.
    Villacorta R; Teeple A; Lee S; Fakharzadeh S; Lucas J; McElligott S
    Br J Dermatol; 2020 Sep; 183(3):548-558. PubMed ID: 31840228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey.
    Thai S; Barlow S; Lucas J; Piercy J; Zhong Y; Zhuo J; Wu JJ
    Dermatol Ther (Heidelb); 2023 Jun; 13(6):1289-1303. PubMed ID: 37253874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining and treating moderate plaque psoriasis: a dermatologist survey.
    Knuckles MLF; Levi E; Soung J
    J Dermatolog Treat; 2018 Nov; 29(7):658-663. PubMed ID: 29502473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.
    Strober B; Greenberg JD; Karki C; Mason M; Guo N; Hur P; Zhao Y; Herrera V; Lin F; Lebwohl M
    BMJ Open; 2019 Apr; 9(4):e027535. PubMed ID: 31005939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement.
    Walters ME; Lee DJ; Yamauchi PS
    J Drugs Dermatol; 2020 Aug; 19(8):698-701. PubMed ID: 32845593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis disease severity affects patient satisfaction with treatment.
    Korman NJ; Zhao Y; Lu J; Tran MH
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient satisfaction with current psoriasis treatment: a real-world study in the USA.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.
    Armuzzi A; Tarallo M; Lucas J; Bluff D; Hoskin B; Bargo D; Cappelleri JC; Salese L; daCosta DiBonaventura M
    BMC Gastroenterol; 2020 Jan; 20(1):18. PubMed ID: 31964359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).
    Lacour JP; Bewley A; Hammond E; Hansen JB; Horne L; Paul C; Reich K; Seneschal J; De Simone C; Sohrt A; Augustin M; Pellacani G
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1099-1109. PubMed ID: 32761560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
    Christophers E; Segaert S; Milligan G; Molta CT; Boggs R
    J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
    Feldman SR; Regnier SA; Chirilov A; Hey F; Gilloteau I; Cella D
    J Am Acad Dermatol; 2019 Jun; 80(6):1650-1657. PubMed ID: 30703461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
    Ighani A; Yu AM; Sandhu VK; Barankin B; Manolson MF
    J Cutan Med Surg; 2019; 23(2):148-156. PubMed ID: 30801221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriatic patients: Analysis of patients dissatisfied with their management].
    Mahé E; Maccari F; Beauchet A; Quiles-Tsimaratos N; Beneton N; Parier J; Barthelemy H; Goujon-Henry C; Chaby G; Thomas-Beaulieu D; Géner G; Wagner L; Pallure V; Devaux S; Vermersch-Langlin A; Pfister P; Jégou J; Livideanu C; Sigal ML;
    Ann Dermatol Venereol; 2017; 144(8-9):497-507. PubMed ID: 28624255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis.
    Zidane M; Dressler C; Gaskins M; Nast A
    JAMA Dermatol; 2019 Dec; 155(12):1380-1389. PubMed ID: 31617856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study.
    Strand V; Fiorentino D; Hu C; Day RM; Stevens RM; Papp KA
    Health Qual Life Outcomes; 2013 May; 11():82. PubMed ID: 23663752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.